The Synthesis of Novelcis-α-Substituted-β-aminotetralins
摘要:
Teteralones were converted, in 1 to 3 steps, to alpha-substituted tetralones. Subsequent reductive amination with ammonium acetate/sodium cyanoborohydride gave the corresponding alpha-substituted-beta-aminotetralins, on a multigram scale, with minimal chromatography for the entire transformation.
The Synthesis of Novelcis-α-Substituted-β-aminotetralins
摘要:
Teteralones were converted, in 1 to 3 steps, to alpha-substituted tetralones. Subsequent reductive amination with ammonium acetate/sodium cyanoborohydride gave the corresponding alpha-substituted-beta-aminotetralins, on a multigram scale, with minimal chromatography for the entire transformation.
N-substituted aminotetralins as ligands for the neuropeptide Y Y5
申请人:Ortho-McNeil Pharmaceutical, Inc.
公开号:US06140354A1
公开(公告)日:2000-10-31
.beta.-Aminotetralin derivatives of the formula: ##STR1## which are ligands for the neuropeptide Y Y5 (NPY5) receptor, methods of preparation and pharmaceutical compositions containing a .beta.-aminotetralin derivative as the active ingredient are described. The .beta.-aminotetralins are useful in the treatment of disorders and diseases associated with NPY receptor subtype Y5.
[EN] N-SUBSTITUTED AMINOTETRALINS AS LIGANDS FOR THE NEUROPEPTIDE Y Y5 RECEPTOR USEFUL IN THE TREATMENT OF OBESITY AND OTHER DISORDERS<br/>[FR] AMINOTETRALINES N SUBSTITUEES, LIGANDS DU RECEPTEUR Y Y5 DU NEUROPEPTIDE SERVANT AU TRAITEMENT DE L'OBESITE ET D'AUTRES TROUBLES
申请人:ORTHO-MCNEIL PHARMACEUTICAL, INC.
公开号:WO1999055667A1
公开(公告)日:1999-11-04
(EN) $g(b)-Aminotetralin derivatives of formula (1): which are ligands for the neuropeptide Y Y5 (NPY5) receptor, methods of preparation and pharmaceutical compositions containing a $g(b)-aminotetralins derivative as the active ingredient are described. The $g(b)-aminotetralins are useful in the treatment of disorders and diseases associated with NPY receptor subtype Y5.(FR) L'invention porte sur des dérivés d'aminotétraline de formule (1) ligands du récepteur Y Y5 (NPY5) du neuropeptide, sur leurs procédés de préparation, et sur des compositions pharmaceutiques les contenant comme principe actif. Les aminotétralines servent pour le traitement de troubles et de maladies liées au sous-type Y5 du récepteur NPY.
N-SUBSTITUTED AMINOTETRALINS AS LIGANDS FOR THE NEUROPEPTIDE Y Y5 RECEPTOR USEFUL IN THE TREATMENT OF OBESITY AND OTHER DISORDERS
申请人:Ortho-McNeil Pharmaceutical, Inc.
公开号:EP1076644B1
公开(公告)日:2004-06-23
US6140354A
申请人:——
公开号:US6140354A
公开(公告)日:2000-10-31
The Synthesis of Novel<i>cis</i>-α-Substituted-β-aminotetralins
作者:Mark A. Youngman、Nicole M. Willard、Scott L. Dax、James J. McNally
DOI:10.1081/scc-120021500
日期:2003.1.7
Teteralones were converted, in 1 to 3 steps, to alpha-substituted tetralones. Subsequent reductive amination with ammonium acetate/sodium cyanoborohydride gave the corresponding alpha-substituted-beta-aminotetralins, on a multigram scale, with minimal chromatography for the entire transformation.